BRIEF-OncBioMune submits protocol for two phase 2 clinical trials

* OncBioMune submits protocol to principal investigators for

two phase 2 clinical trials of proscavax for prostate cancer

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom:...

Read more